These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11233517)

  • 61. [The clinical meaning of the emergence of viral breakthrough during lamivudine treatment in patients with hepatitis B virus related chronic liver disease].
    Park CB; Lim HJ; Yun BC; Lee SU; Han BH
    Korean J Hepatol; 2004 Jun; 10(2):108-16. PubMed ID: 15218344
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The duration of lamivudine therapy for chronic hepatitis B: cessation vs. continuation of treatment after HBeAg seroconversion.
    Fung J; Lai CL; Tanaka Y; Mizokami M; Yuen J; Wong DK; Yuen MF
    Am J Gastroenterol; 2009 Aug; 104(8):1940-6; quiz 1947. PubMed ID: 19455108
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Therapeutic advances in chronic hepatitis B.
    Lai CL
    J Gastroenterol Hepatol; 2004 Mar; 19 Suppl():S5-9. PubMed ID: 15156927
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lamivudine therapy of chronic hepatitis B.
    Hunt CM; Brown NA; Rubin M
    Adv Exp Med Biol; 1999; 458():11-21. PubMed ID: 10549375
    [No Abstract]   [Full Text] [Related]  

  • 65. Lamivudine treatment of chronic hepatitis B.
    Dusheiko G
    Rev Med Virol; 1998 Jul; 8(3):153-159. PubMed ID: 10398503
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Built to last? Durability of lamivudine-induced seroconversion in patients with chronic hepatitis B.
    Wang CC; Kowdley KV
    Gastroenterology; 2004 Jun; 126(7):1917-9. PubMed ID: 15188197
    [No Abstract]   [Full Text] [Related]  

  • 67. Synthesis, characterization and biological activity of a niobium-substituted-heteropolytungstate on hepatitis B virus.
    Zhang H; Qi Y; Ding Y; Wang J; Li Q; Zhang J; Jiang Y; Chi X; Li J; Niu J
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1664-9. PubMed ID: 22264474
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2 2.2.15 cells.
    Huang KL; Lai YK; Lin CC; Chang JM
    World J Gastroenterol; 2006 Sep; 12(35):5721-5. PubMed ID: 17007029
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical applications of molecular biology for infectious diseases.
    Speers DJ
    Clin Biochem Rev; 2006 Feb; 27(1):39-51. PubMed ID: 16886046
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lamivudine therapy for children with chronic hepatitis B.
    Liberek A; Szaflarska-Popławska A; Korzon M; Łuczak G; Góra-Gebka M; Łoś-Rycharska E; Bako W; Czerwionka-Szaflarska M
    World J Gastroenterol; 2006 Apr; 12(15):2412-6. PubMed ID: 16688835
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A preliminary benefit-risk assessment of lamivudine for the treatment of chronic hepatitis B virus infection.
    Zoulim F
    Drug Saf; 2002; 25(7):497-510. PubMed ID: 12093308
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy of lamivudine in HBeAg-negative chronic hepatitis B.
    Rizzetto M
    J Med Virol; 2002 Apr; 66(4):435-51. PubMed ID: 11857520
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Lamivudine for the treatment of chronic hepatitis B.
    Dixon JS; Boehme RE
    Acta Gastroenterol Belg; 2000; 63(4):348-56. PubMed ID: 11233517
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy.
    Leung NW; Lai CL; Chang TT; Guan R; Lee CM; Ng KY; Lim SG; Wu PC; Dent JC; Edmundson S; Condreay LD; Chien RN;
    Hepatology; 2001 Jun; 33(6):1527-32. PubMed ID: 11391543
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A 3-year clinical trial of lamivudine in treatment of patients with chronic hepatitis B.
    Yao GB; Cui ZY; Wang BE; Yao JL; Zeng MD
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):188-93. PubMed ID: 15138107
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [The long-term efficacy of lamivudine in chronic hepatitis B: interim analysis of 3-year's clinical course].
    Yao GB; Wang BE; Cui ZY; Yao JL; Zeng MD
    Zhonghua Nei Ke Za Zhi; 2003 Jun; 42(6):382-7. PubMed ID: 12895320
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.